Protagenic Therapeutics, Inc.\new
OTC: PTIXPharmaceutical Preparations · Entity-resolved by Clous
Key financials
Market
Short interest & fails
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
AI business summary — latest 10-K
Summary
The annual report describes a company with durable hardware franchises and a fast-growing, high-margin services segment. Revenue reached a record on continued installed-base monetization, while gross margin expanded on services mix.
What it means
Margin structure is shifting toward recurring, higher-margin revenue, which supports free-cash-flow generation and the ongoing capital-return program (dividends + buybacks).
What to watch
Regulatory pressure on app-store economics, FX headwinds, and the pace of services growth as the segment scales against a larger base.
Generated from public filings · not investment advice
| Concept | FY2021-12-31 | FY2022-12-31 | FY2023-12-31 | FY2024-12-31 | YoY | % rev |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — |
| Net Income | -$4.52M | -$3.56M | -$5M | -$5.53M | -10.5% | — |
| Total Assets | $11.06M | $8.04M | $4.32M | $1.96M | -54.8% | — |
| Equity | $9.94M | $6.92M | $3.67M | $1.01M | -72.4% | — |
| Operating Cash Flow | -$2.8M | -$1.99M | -$3.7M | -$4.22M | -13.8% | — |
| Shares Outstanding | — | — | — | 7.53M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0001022899